SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 291
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
Advertisement
U.S. Stocks Decline As Greece Uncertainty Lingers
U.S. stocks ended Monday's choppy session slightly lower as global equities came under pressure after Greece on Sunday rejected its international lenders' bailout terms and moved closer to a potential exit from the eurozone.
Top Equities Stories Of The Day
Humana Cuts Profit View On Higher Medical Costs -- 4th Update
Electrolux's Plan to Buy GE's Appliances Unit Doesn't Worry Major Customers
Starbucks Raises Prices by About 1%
McDonald's, KFC Look to Get Faster in China
Big U.S. Banks Refile 'Living Wills' After Regulatory Rebuke -- Update
Fiat Chrysler's Elkann Confident Auto Industry Will Move Toward Mergers
AMD Sees Revenue Sliding
Train Carrying Toxic Gas Derails in Tennessee
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 660108 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist